{"database": "lobbying", "table": "lobbying_activities", "rows": [[1443224, "f675a849-dda3-41ab-a116-add67b24b2c1", "Q3", "NOVO NORDISK INC.", 284790, "NOVO NORDISK INC.", 2013, "third_quarter", "PHA", "H.R. 3204 Drug Quality and Security Act, H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)", null, 500000, 0, 0, "2013-10-15T16:29:26.333000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1443224"], "units": {}, "query_ms": 29.302355949766934, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}